ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc., an early-stage ophthalmic medical device company, is expanding its operations with the opening of its new headquarters in Albuquerque, NM. The new facilities consisting of office, development labs, and manufacturing space will meet the needs of the company’s growth through its next stage of development and commercialization.
“The company has a fully staffed R&D team with state-of-the-art optical labs, optometry lane, and machine shops in place to drive our development efforts forward. The new office space is the first of several important changes for the organization as we prepare for the exciting road ahead.”
“This is not a typical seed-stage startup,” said Dan Neal, CEO. “The company has a fully staffed R&D team with state-of-the-art optical labs, optometry lane, and machine shops in place to drive our development efforts forward. The new office space is the first of several important changes for the organization as we prepare for the exciting road ahead.”
The company’s Chief Operations Officer, Ron Rammage, expressed enthusiasm about the new space, stating, “The 9,800 sq. ft. facility allows for the team’s continued expansion of R&D efforts and the ability to scale its manufacturing capacity supporting future product launches. The space also enables our workers to stay safe and maintain good physical distancing to operate within current state and local COVID-19 guidelines.”
The ophthalmic industry continues to undergo significant advancements and innovation with the pursuit of improving vision. The founders of WaveFront Dynamics have decades of ophthalmic industry experience and are dedicated to advancing solutions for the visually impaired.
About WaveFront Dynamics Inc.
Founded in 2019, WaveFront Dynamics Inc. (WaveDyn) is a privately held, early-stage medical device company with innovative wavefront diagnostic technology for use in the ophthalmic industry. The eye, like all living structures, is a constantly changing and adapting system. Today, most diagnostic systems measure the eye as a snapshot in time. WaveDyn’s approach is to measure the eye dynamically, like a movie. The regular (sphero-cylindrical) refractive errors and irregularities (aberrations) can lead to a potentially significant reduction in visual function. The company plans to leverage the dynamic measurements to yield new insights into assessing visual performance, advancing treatment options, and improving quality of life for the visually impaired. For further information, please contact Dan Neal, CEO at dan.neal@wavdyn.com and our website www.wavdyn.com.